Speakers

Keynote

The Versatile Macrophage: Receptors and Inflammation
Siamon Gordon, M.D., Ph.D.
Emeritus Professor of Cellular Pathology, University of Oxford
Visiting Scientist at the NIH

Symposium Titles & Co-Chairs

1. Tissue Crosstalk in Inflammation and Metabolism: Adipokines and Myokines
   
   Co-chairs: Steven Simpson, Ph.D. (GSK) & Ken Walsh, Ph.D., (Boston Univ)

   Speaker 1: Gokhan Hotamisligil, M.D., Ph.D. (Harvard)
   Reciprocity of Metabolism and Inflammation
   
   Speaker 2: Ken Walsh, Ph.D. (Boston Univ)
   Adipokines, Myokines and Metabolic Disease
   
   Speaker 3: Bente Pederson, M.D. (Univ of Copenhagen)
   Skeletal Muscle as an Endocrine Organ: The Rold of Myokines in Muscle-Fat Cross-Talk
   
   Speaker 4: Jennifer Lachey, Ph.D. (Acceleron Pharma)
   Treatment with a Soluble Activin Receptor Type IIB Attenuates Diet-Induced Obesity in High-Fat Diet-Fed Mice
    

2. ADVANCES in Translational Medicine as it Applies to Inflammatory Diseases

   Co-Chairs: Lisa Schopf, Ph.D. (Abbott) & Bill Selig, Ph.D.
   
   Speaker 1: Jeff Voss, Ph.D. (Abbott)
   Translation of Pre-Clinical Models to the Human Autoimmune Diseases
   
   Speaker 2: Bitao Liang, Ph.D. (Celgene)
   Immune Modulatory Properties of Human Placenta-Derived Stem Cells
   
   Speaker 3: Christine Ward, Ph.D. (MedImmune)
   Translational Strategies to Facilitate Inflammatory Drug Development
   
   Speaker 4: William Westlin, Ph.D. (Avila Therapeutics)
   Translational Pharmacology of AVL-292, A Potent and Selective Inhibitor of Bruton’s Tyrosine Kinase
    

3. Molecular and Cellular Crosstalk in Inflammation Network: the Role of Macrophages and Dendritic Cells
   
   Co-Chairs: Annalisa D'Andrea, Ph.D. (SRI Int Biosciences) & Liwu Li, Ph.D. (Virginia Tech)
   
   Speaker 1: Giorgio Trinchieri, M.D. (NCI)
   Innate Resistance, Inflammation and Cancer
   
   Speaker 2: Dan Cua, Ph.D. (Merck)
   C-type Lectin Activation of an Alternative Macrophage Population
   
   Speaker 3: Carla Rothlin, Ph.D. (Yale)
   TAMing Inflammation In Vivo
   
   Speaker 4: Kate Fitzgerald, Ph.D. (U Mass)
   AIM2 Inflammasomes in Anti-Microbial Defenses.
    
4. Lupus: From Basic Mechanisms to the Clinic
   
   Co-Chairs: Laura Carter, Ph.D. (Array BioPharma) & Joan Merrill, M.D. (Oklahoma Medical Res Found)
   
   Speaker 1: Laura Carter, Ph.D. (Array BioPharma)
   Introduction to Lupus
   
   Speaker 2: Gregg Silverman, M.D. (UCSD)
   Roles of B Cells in Lupus Pathogenesis
   
   Speaker 3: Franck Barrat, Ph.D. (Dynavax)
   Plasmacytoid Dendritic Cell Activation Hampers Glucocorticoids Anti-Inflammatory Activity in SLE
   
   Speaker 4: Joan Merrill, M.D. (Oklahoma Medical Res Found)
   Overview of Lupus Clinical Development Programs
    
5. Novel Therapeutics
   
   Co-Chairs: Bruce Tomczuk, Ph.D. (Arginetix) & Spencer Danto, M.D., Ph.D. (Pfizer)
   
   Speaker 1: To Be Named
   
   Speaker 2: To Be Named
   
   Speaker 3: To Be Named

Mini Symposia (not finalized)

1. Innate Immune Responses
   Co-Chairs: Laurent Audoly, Ph.D. (Merck) & Bassil Dahiyat, Ph.D. (Xencor)
   Invited Speaker: Basil Dahiyat, Ph.D. (Xencor)
   Tuning Effector Cell Responses to MAb Therapies via Fc Engineering: Clinical and Pre-Clinical Experiences
   
   Plus 5 oral presentations selected from submitted abstracts
    
2. Adaptive Immune Responses
   (Co-Chairs: to be named)
   1 invited speaker (co-chair) + 4-5 selected abstracts

^ TOP of PAGE